Delivery Order SPE2DB24D2205-SPE2DB24FDVLU

Award Date 6/12/24
Potential Completion Date 7/5/24
Potential Value $47K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA) for a total ceiling value of $4,685.05. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA) Troop Support Medical program. The firm fixed price delivery order, valued at $1,911.94, has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This federal contract award, valued at $47,798.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of VARIVAX vaccine with diluents and has a performance period through April 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this firm fixed price delivery order. The company also holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order valued at $1,911.94 to provide VARIVAX vaccine with diluents. This award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025, for the provision of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a delivery order contract worth $134,929.44 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of VARIVAX vaccine with diluents. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the...
The Defense Logistics Agency (DLA) awarded a $1,874.02 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division for the supply of VARIVAX vaccine with diluents. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $13,383.58 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide VARIVAX vaccine with diluents. This delivery order is part of a larger single-award indefinite delivery contract (IDC) with a potential value of $999,999,999.00, awarded by DLA to Amerisourcebergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies to support...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a Firm Fixed Price delivery order contract valued at $9,559.70 to provide VARIVAX vaccine with diluents. This award does not have a set-aside designation and the performance period runs through March 18, 2024. Amerisourcebergen Drug Corp is a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, primarily the...
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is for the delivery of Varivax vaccine with diluents to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,867.91 and is a firm fixed price delivery order with an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA). The contract, valued at $5,622.06, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDVLU
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, is for the supply of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $46,850.50, is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA. The IDC, valued up to $999,999,999.00 through December 31, 2025, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract does not have a set-aside designation.

Generated 9/11/24, 9:50 AM